These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 12728671)
1. [The evaluation of natural anticoagulants in systemic lupus erythematosus in children]. Matuszewska E; Grygalewicz J; Wygledowska G; Mazurkiewicz H Pol Merkur Lekarski; 2003 Feb; 14(80):125-9. PubMed ID: 12728671 [TBL] [Abstract][Full Text] [Related]
2. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus. Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323 [TBL] [Abstract][Full Text] [Related]
3. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123 [TBL] [Abstract][Full Text] [Related]
4. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
5. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
6. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633 [TBL] [Abstract][Full Text] [Related]
7. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. Mader R; Ziv M; Adawi M; Mader R; Lavi I J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901 [TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]. Sarzi-Puttini P; Atzeni F; Carrabba M Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related]
11. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674 [TBL] [Abstract][Full Text] [Related]
12. Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Spadaro A; Scrivo R; Bombardieri M; Riccieri V; Rinaldi T; Taccari E; Valesini G Clin Rheumatol; 2003 May; 22(2):107-11. PubMed ID: 12740674 [TBL] [Abstract][Full Text] [Related]
13. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400 [TBL] [Abstract][Full Text] [Related]
14. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257 [TBL] [Abstract][Full Text] [Related]
20. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]